NO975713D0 - Chelaterende polymere som kontrastmidler for medisinsk billeddannelse - Google Patents

Chelaterende polymere som kontrastmidler for medisinsk billeddannelse

Info

Publication number
NO975713D0
NO975713D0 NO975713A NO975713A NO975713D0 NO 975713 D0 NO975713 D0 NO 975713D0 NO 975713 A NO975713 A NO 975713A NO 975713 A NO975713 A NO 975713A NO 975713 D0 NO975713 D0 NO 975713D0
Authority
NO
Norway
Prior art keywords
medical imaging
contrast agents
chelating polymers
chelating
polymers
Prior art date
Application number
NO975713A
Other languages
English (en)
Other versions
NO975713L (no
Inventor
Kenneth Robert Hollister
Kenneth Edmond Keller
Dong Wei
Xin Peng
David Lee Ladd
Robert Allen Snow
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO975713D0 publication Critical patent/NO975713D0/no
Publication of NO975713L publication Critical patent/NO975713L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
NO975713A 1995-06-07 1997-12-05 Chelaterende polymere som kontrastmidler for medisinsk billeddannelse NO975713L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,803 US5801228A (en) 1995-06-07 1995-06-07 Polymeric contrast agents for medical imaging
PCT/GB1996/001308 WO1996040274A2 (en) 1995-06-07 1996-06-03 Chelating polymers as contrast agents for medical imaging

Publications (2)

Publication Number Publication Date
NO975713D0 true NO975713D0 (no) 1997-12-05
NO975713L NO975713L (no) 1998-02-02

Family

ID=23901417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975713A NO975713L (no) 1995-06-07 1997-12-05 Chelaterende polymere som kontrastmidler for medisinsk billeddannelse

Country Status (9)

Country Link
US (1) US5801228A (no)
EP (1) EP0831930A1 (no)
JP (1) JP2001507378A (no)
KR (1) KR19990022575A (no)
CN (1) CN1192160A (no)
AU (1) AU5841596A (no)
CA (1) CA2223456A1 (no)
NO (1) NO975713L (no)
WO (1) WO1996040274A2 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027498A1 (en) * 1993-05-20 1994-12-08 The Regents Of The University Of California Macromolecular contrast media for mr imaging
WO1998010797A2 (en) * 1996-09-12 1998-03-19 Nycomed Imaging As Marker compositions
US6060040A (en) 1996-12-23 2000-05-09 Bracco Research S.A. Cross-linked polymeric compositions for increasing the MRI contrast in visualising the digestive tract of patients
AU7066698A (en) * 1997-04-22 1998-11-13 Nycomed Imaging As Nmr image compounds
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6524553B2 (en) * 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) * 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6818626B1 (en) * 1998-07-17 2004-11-16 Mirus Corporation Chelating systems for use in the delivery of compounds to cells
JP2000086538A (ja) * 1998-09-17 2000-03-28 Toshihiro Akaike Ｍｒｉ用造影剤
CN1356913A (zh) 1998-12-18 2002-07-03 杜邦药品公司 玻连蛋白受体拮抗剂药物
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
AU2371400A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) * 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6656448B1 (en) 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
AU2001261728A1 (en) * 2000-05-17 2001-11-26 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
IL147629A0 (en) 2000-06-01 2002-08-14 Bristol Myers Squibb Pharma Co LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
WO2002036173A2 (en) * 2000-11-03 2002-05-10 Bristol-Myers Squibb Pharma Company Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US20090062256A1 (en) * 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
HUP0401904A3 (en) * 2001-08-08 2009-01-28 Bristol Myers Squibb Pharma Co Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20050106101A1 (en) * 2003-10-31 2005-05-19 Ajay Purohit Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
US7485283B2 (en) * 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US20060083681A1 (en) * 2004-10-18 2006-04-20 Ajay Purohit Compounds for myocardial perfusion imaging
CN101252954A (zh) * 2005-06-30 2008-08-27 布里斯托尔-迈尔斯斯奎布药品公司 作为显像剂的酰肼偶联物
US7824659B2 (en) 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
US20070202047A1 (en) * 2006-01-05 2007-08-30 Markus Wolf Polyamine-substituted ligands for use as contrast agents
BRPI0718360A2 (pt) 2006-12-04 2013-11-12 Univ Illinois "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg"
WO2008098216A2 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
PT2257315T (pt) 2008-02-29 2020-01-27 Lantheus Medical Imaging Inc Agentes de contraste para aplicações incluindo imagiologia de perfusão
JP5311982B2 (ja) * 2008-11-21 2013-10-09 大和製罐株式会社 イミドオリゴマー及びこれを加熱硬化させてなるポリイミド樹脂
CA2758883C (en) 2009-04-15 2020-03-10 Lantheus Medical Imaging, Inc. Stabilization of radiopharmaceutical compositions using ascorbic acid
EP2534136B1 (en) 2010-02-08 2017-09-06 Lantheus Medical Imaging, Inc. Methods for synthesizing imaging agents, and intermediates thereof
FR2983861B1 (fr) * 2011-12-09 2016-01-08 Centre Nat Rech Scient Copolymere hydrophobe visible en irm
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
WO2018053460A1 (en) * 2016-09-19 2018-03-22 The Regents Of The University Of California Paramagnetic polymers
CN106977714A (zh) * 2017-03-03 2017-07-25 广州军区广州总医院 正电子标记纳米探针68Ga‑NOTA‑DGL‑Ac及其制备方法与用途
KR20230146177A (ko) 2022-04-11 2023-10-19 주식회사 아이디엇 파우치형 기능성 명함

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34615A (en) * 1969-06-11 1974-11-29 Stauffer Chemical Co Ethylenediaminetetraacetic acid derivatives and their preparation
US4707453A (en) * 1985-04-05 1987-11-17 Becton Dickinson And Company Vesicle including a metal marker for use in an assay
DK172629B1 (da) * 1986-02-14 1999-03-22 Nihon Mediphysics Co Ltd Reaktive højmolekylære forbindelser med mindst én fri aminogruppe, højmolekylære forbindelser kombineret med et fysiologisk
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
CS273274B1 (en) * 1988-05-11 1991-03-12 Smidrkal Jan Method of alkaline polymer amides production
US5914095A (en) * 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
GB9320277D0 (en) * 1993-10-01 1993-11-17 Nycomed Salutar Inc Chelants
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
IE920996A1 (en) * 1991-03-27 1992-10-07 Nycomed Salutar Contrast media
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
AU660033B2 (en) * 1991-05-23 1995-06-08 Imarx Pharmaceutical Corp. Liposoluble compounds for magnetic resonance imaging
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
JPH08502528A (ja) * 1992-10-14 1996-03-19 スターリング ウィンスロップ アイエヌシー． キレート化ポリマー
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5466439A (en) * 1992-11-12 1995-11-14 Magnetic Research, Inc. Polymeric contrast enhancing agents for magnetic resonance images
US5730968A (en) * 1994-03-31 1998-03-24 Sterling Winthrop Inc. Segmented chelating polymers as imaging and therapeutic agents

Also Published As

Publication number Publication date
NO975713L (no) 1998-02-02
AU5841596A (en) 1996-12-30
MX9709787A (es) 1998-07-31
WO1996040274A3 (en) 1997-02-13
KR19990022575A (ko) 1999-03-25
CA2223456A1 (en) 1996-12-19
JP2001507378A (ja) 2001-06-05
EP0831930A1 (en) 1998-04-01
CN1192160A (zh) 1998-09-02
US5801228A (en) 1998-09-01
WO1996040274A2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
NO975713D0 (no) Chelaterende polymere som kontrastmidler for medisinsk billeddannelse
DE69624770T2 (de) Chirurgischer Klemmechanismus
BR7603560Y1 (pt) aparelho de projeção de vìdeo.
DE69621595D1 (de) Knochentransplantat-verbindungen
DE69606550T2 (de) Medizinischen verbindungsanordnung
DE69814070T2 (de) Sterilisationsverfahren
NO963417L (no) Desinfeksjonsanordning
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO965301D0 (no) 2,4,6-trijod-5-substituerte-amino-isoftalatestere nyttige som röntgenkontrastmidler for medisinsk diagnostisk billeddannelse
NO305438B1 (no) Diagnostisk avbildningsmiddel
TR199601018A1 (tr) Farmasötik bilesikler.
NL1000591C2 (nl) Weefsel.
KR960030492U (ko) 의료용 멸균기
ES1031513Y (es) Moldeador de zocalos para dentaduras.
DE29515342U1 (de) Sterilisationsautoklav
DE29515341U1 (de) Sterilisationsautoklav
FR2710832B1 (fr) Articulateur dentaire.
ES1028514Y (es) Implante dental.
KR960033519U (ko) 살균 소독고
DE29820295U1 (de) Modulares augenärztliches Untersuchungssystem
ES1027473Y (es) Boton quirurgico de traccion ortodoncia.
ES1030449Y (es) Estuche de servicio dental.
BR7502254U (pt) Posicionador para radiografia interproximal
IT1281291B1 (it) Apparecchio sanitario.
ES1031891Y (es) Consola perfeccionada.